Get the tools used by (smart)2 investors.

Genomma Lab Internacional SAB de CVOTCPK:GNML.F

Mexico / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
1.43 USD
Price
0.00 (0.00%)
Day change
0.79 - 1.43
52-week range

Summary of Genomma Lab Internacional SAB de CV

Hide this widget

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and ...

Dec 31, 2024
Latest Report
Apr 30, 2025
Next Earnings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data could not be retrieved

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  GNML.F Peers Sector
Market Cap
1.096 B3.67 B61.318 M
Price % of 52 Week High
100.0%73.7%58.8%
Dividend Yield
0.0%3.1%0.0%
Shareholder Yield
10.4%3.7%-0.7%
1 Year Price Total Return
55.4%3.6%-15.5%
Beta (5 Year)
0.550.490.64

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for Genomma Lab Internacional is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developing economic markets.

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue863970892208224
Operating Income1661921914149
Net Profit7164103(3.60)23
Diluted EPS0.0720.0670.10-0.00380.023
EBITDA1782052084354
Balance Sheet
Cash & ST Invest.779711097110
Current Assets580628620628620
Total Assets1,1091,2211,1551,2211,155
Current Liabilities480390324390324
Total Liabilities588665599665599
Total Equity521556556556556
Total Debt331367311367311
Cash Flow Statement
Cash Flow Operations1051321464862
Cash From Investing(25)(18)(35)(19)(1.47)
Cash From Financing(70)(99)(76)(40)(30)
Free Cash Flow851181334454

Analyst Notes

April 13, 2025
Hide this widget
    All rights reserved. Terms Of Use